Impacts of the COVID-19 Pandemic to the Skin and to Professionals Caring for the Skin
Journal Title: Journal of Dermatology Research - Year 2020, Vol 1, Issue 1
Abstract
This is a brief review on the impact of Coronavirus disease 2019 (COVID-19) pandemic on the skin and the practice of dermatology. There are many skin manifestations of COVID-19. The most characteristic one would be multiple acrally-located erythematous perniosis-like swellings occuring in babies and small children [1-4]. These lesions are usually late in presentation. Vesicular eruptions appear early in the phase of the disease [1]. These two types of lesions are the most specific patterns [1]. Non-pitting oedema on the hands and feet can sometimes be seen. Less commonly, lesions are seen on the face, trunk and ears [4]. They are mainly seen in the European countries and Middle East. To the best knowledge of the Editor, no such lesion has yet been reported in infants and young children in Asia, including South-East Asia. Other skin manifestations include a petechial rash on the trunk, non-specific exanthem and acute urticaria [5-8]. The impacts of COVID-19 are beyond cutaneous manifestations for the infected patients. As an example, for children with severe skin diseases, unrelated to COVID-19 and on immunosuppressant therapies, most pediatric dermatologists have paused or reduced the frequency of laboratory monitoring for adverse effects of the medications [9].
Authors and Affiliations
Antonio Chuh
Keywords
Related Articles
- EP ID EP699027
- DOI http://dx.doi.org/10.46889/JDR.2020.1101
- Views 94
- Downloads 0
Insurance Trends in Patients Diagnosed with Melanoma Before and After the Affordable Care Act: A National Database Study
Background: The Affordable Care Act (ACA) was intended, in part, to reduce the uninsured population. It underwent full implementation in 2014 with optional state Medicaid expansion and health insurance marketplaces. Prio...
Nifuroxazide Erythema Pigmented Fixed: A Side Effect to Be Aware Off
Erythema Pigmentum Fixata (EPF) is a delayed-type toxidermia. It manifests itself within 48 h after the re-introduction of a drug by the appearance of a recurrent rash, leaving a residual hyperpigmentation [1]. We report...
JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
Baricitinib, a JAK1/2 inhibitor, has been expanding its role as a therapeutic agent with recent FDA approval for dermatologic use with alopecia areata. Clinical trials are underway for further use of baricitinib for seve...
Observed Causal Relationship Between Eczema and Inflammatory Bowel Diseases
Over the past 27 years in my functional medicine clinical practice, I have had 10 or more patients present with chronic and acute cases of eczema. After taking a thorough history, ordering blood tests and food intoleranc...
The Sinewy Scruff-Nuchal-Type Fibroma
Nuchal-type fibroma is an uncommon, benign, tumour-like, subcutaneous nodule comprised of bundles of thick collagen fibres confined to dermis and subcutaneous tissue of posterior neck. The condition commonly appears wi...